The Effects of remimazolam tosilate combined with sufentanil on hemodynamics and depth of anesthesia in patients with painless gastrointestinal endoscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042441

Enrollment

Unknown

Registered

2021-01-21

Start date

2021-02-01

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease of digestive tract

Interventions

trial group:Remimazolam tosilate

control group:propofol

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients undergoing gastrointestinal endoscopy; Patients with ASA I~II; Patients who 4MET; Patients who voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: Patients with oral sedatives and antidepressants before surgery; Patients with preoperative difficult airway, Mallampati grade > grade III; Patients who are allergic or contraindicated to experimental drugs and auxiliary drugs; Patients deemed unsuitable to participate in the study by the researcher.

Design outcomes

Primary

Measure	Time frame
Hemodynamics;	—

Secondary

Measure	Time frame
respiratory rate (RR);bispectral index, BIS;	—

Countries

China

Contacts

Public ContactMa Xianchun

Rizhao Central Hospital

rzmaxianchun@163.com+86 13863327378

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026